All Pharma articles – Page 38
-
NewsAlistair Darling pledges research and development boost for pharmaceutical industries
Chancellor Alistair Darling has said he wants to encourage research and development in the pharmaceutical and biotechnology industries, announcing a new lower 10 pence corporation tax on income which stems from patents in the UK.
-
NewsPharmacists acting as 'safety net'
Pharmacists are regularly correcting doctors’ mistakes with medicines, according to research.
-
NewsLincolnshire to reward cheaper GP prescribing
GPs in Lincolnshire are being offered incentives worth up to £2 per head of practice population to cut antibiotic prescribing and increase use of generic drugs.
-
NewsNICE highlights guidance to save NHS money
The National Institute for Health and Clinical Excellence has collected together evidence it believes could save the NHS hundreds of millions of pounds.
-
NewsConfused patients appeal for simplified NHS regulation
Health profession regulators should standardise how they work, or even merge, to improve safety, patient groups have said.
-
Community
Dutch fluffiness
If you think British politicians are unhelpful in their tendency to pay more attention to Daily Mail headlines than rational decision making, pity the poor Dutch.
-
NewsDementia drugs warning
Powerful anti-psychotic drugs intended to treat schizophrenia are reportedly being regularly used to “chemically cosh” elderly dementia patients.
-
Information50 Ben Goldacre
An honourable 50th position for the NHS’s own myth buster - The Guardian columnist and author of Bad Science Dr Ben Goldacre.
-
Information36 Richard Barker
Director general of the Association of British Pharmaceutical Industries, Richard Barker has been at the heart of many wrangles over drug costs and availability.
-
Information09 Sir Michael Rawlins
It has been another eventful year for Professor Sir Michael Rawlins, who was reappointed as chair of the National Institute for Health and Clinical Excellence in March after a special exemption allowed him to extend his tenure.
-
NewsMicrosoft on the lookout for NHS business
Microsoft is “investigating opportunities” for introducing its personal health record platform in the NHS in England.
-
CommentMedia Watch: drugs debate
The sacking of senior government adviser David Nutt has resulted in the biggest media debate on illegal drugs for many months.
-
NewsDrug firm to compensate NHS
Scotland’s health secretary Nicola Sturgeon has welcomed a settlement being reached with a pharmaceutical company over alleged anti-competitive behaviour in the supply of drugs to the NHS.
-
NewsPCTs defend closer working with NICE
Primary care trusts and the National Institute for Health and Clinical Excellence have defended a £300,000 a year contract designed to help PCTs influence NICE appraisals.
-
HSJ Knowledge
Joint working with the pharmaceutical industry
Steve Williamson, Sean McGrath and Abbie Pound explore the importance of collaborative working between healthcare providers and the pharmaceutical industry - facilitated by medical education agencies - and what this might mean for patient care
-
InformationIan Dalton's swine flu update - vaccine distribution plans
In his weekly update for HSJ and Nursing Times, national director for NHS flu resilience Ian Dalton discusses the latest developments in UK swine flu preparations
-
NewsMedication errors 'affect 70pc of care home residents'
Overworked care home staff, poor teamwork and lack of training mean seven in 10 elderly residents are subject to medication errors.
-
NewsScottish prescription costs soar to £1.07bn
Prescriptions are now costing the NHS in Scotland £1.07bn a year, latest figures show.
-
NewsPressure to follow NICE guidelines 'will increase'
The public spending squeeze means primary care trusts are likely to come under greater scrutiny over their following of recommendations in National Institute for Health and Clinical Excellence guidelines and technology appraisals.
-
NewsHospital changes prescription practices after chemotherapy overdose
A Bristol hospital has announced a range of “robust” changes to its prescription practices after a consultant killed a patient by accidentally administering a chemotherapy dose four times higher than the recommended limit.